---
figid: PMC4487054__ol-10-01-0023-g00
figlink: /pmc/articles/PMC4487054/figure/f1-ol-0-0-3182/
number: Figure 1
caption: 'Signaling of SGK3 and AKT. Activation of PI3K leads to phosphorylation of
  PDK1, subsequently leading to phosphorylation and activation of AKT and SGK3. Cell
  survival and cell growth/proliferation: By regulating the downstream targets, SGK3
  and AKT show a parallel function in cell survival (Bcl-xL, BAD, FKHRs, GSK3-β) and
  cell growth/proliferation (GSK3-β, TSC2, PRAS40). SGK3 also induces cell survival
  by downregulating CXCR4 through the interaction with ubiquitin ligase AIP4. SGK3
  mediates ER-positive cancer cells survival by phosphorylating its co-activator,
  FLI-I. Angiogenesis: PI3K signaling pathways involve in the Foxc2-mediated angiogenesis
  process. Inhibition of GSK3-β by PI3K/AKT up-regulates the expression of HIF-1α,
  which induces VEGF transcriptional activation to promote angiogenesis. ○Resistin
  activates PI3K/AKT to increase the interaction with Sp1, resulting in upregulation
  of VEGF expression to promote angiogenesis. ★PI3K/AKT is mediated by Id1 to enhance
  EPC angiogenesis in ovarian cancer. ∆By regulating PI3K/PTEN/AKT/GSK-3β pathway,
  HIV-1 Tat in KSHV vIL-6-induced angiogenesis. SDF-1/CXCR4 receptor ligand system
  up-regulates VEGF expression to promote angiogenesis. Hypothesis: The red arrow
  pathways are our hypothesis: SGK3 may involve in tumor angiogenesis by regulating
  CXCR4 or/and GSK-3β. PI3K, phosphoinositide 3-kinase; PDK1, 3-phosphoinositide-dependent
  kinase 1; AKT, v-akt murine thymoma viral oncogene homolog; SGK3, serum- and glucocorticoid-inducible
  protein kinase 3; Bcl-xL, B-cell lymphoma-extra large; FKHRs, forkhead family of
  transcription factors; BAD, Bcl-2-associated death promoter; FLI-I, flightless-I;
  GSK3-β, glycogen synthase kinase-β; TSC2, tuberous sclerosis factor 2; PTEN, phosphatase
  and tensin homolog; PRAS40, proline-rich AKT substrate of 40 kDa; SDF-1, stromal
  cell-derived factor 1; CXCR4, C-X-C chemokine receptor type 4; HIF1α, hypoxia-inducible
  factor-1α; VEGF, vascular endothelial growth factor; Id1, inhibitor of DNA binding/differentiation
  1; EPC, endothelial progenitor cell; KSHV vIL-6, Kaposi''s sarcoma-associated herpesvirus
  viral interleukin-6; HIV-1, human immunodeficiency virus type 1; Tat, transactivator
  of transcription; ER, estrogen receptor; AIP4, atrophin-1-interacting protein 4;
  FOXC2, forkhead box protein C2; Sp1, specificity protein 1.'
pmcid: PMC4487054
papertitle: SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).
reftext: MINZHI HOU, et al. Oncol Lett. 2015 Jul;10(1):23-26.
pmc_ranked_result_index: '166256'
pathway_score: 0.967458
filename: ol-10-01-0023-g00.jpg
figtitle: Signaling of SGK3 and AKT
year: '2015'
organisms: Homo sapiens
ndex: c4c2d9a0-decc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4487054__ol-10-01-0023-g00.html
  '@type': Dataset
  description: 'Signaling of SGK3 and AKT. Activation of PI3K leads to phosphorylation
    of PDK1, subsequently leading to phosphorylation and activation of AKT and SGK3.
    Cell survival and cell growth/proliferation: By regulating the downstream targets,
    SGK3 and AKT show a parallel function in cell survival (Bcl-xL, BAD, FKHRs, GSK3-β)
    and cell growth/proliferation (GSK3-β, TSC2, PRAS40). SGK3 also induces cell survival
    by downregulating CXCR4 through the interaction with ubiquitin ligase AIP4. SGK3
    mediates ER-positive cancer cells survival by phosphorylating its co-activator,
    FLI-I. Angiogenesis: PI3K signaling pathways involve in the Foxc2-mediated angiogenesis
    process. Inhibition of GSK3-β by PI3K/AKT up-regulates the expression of HIF-1α,
    which induces VEGF transcriptional activation to promote angiogenesis. ○Resistin
    activates PI3K/AKT to increase the interaction with Sp1, resulting in upregulation
    of VEGF expression to promote angiogenesis. ★PI3K/AKT is mediated by Id1 to enhance
    EPC angiogenesis in ovarian cancer. ∆By regulating PI3K/PTEN/AKT/GSK-3β pathway,
    HIV-1 Tat in KSHV vIL-6-induced angiogenesis. SDF-1/CXCR4 receptor ligand system
    up-regulates VEGF expression to promote angiogenesis. Hypothesis: The red arrow
    pathways are our hypothesis: SGK3 may involve in tumor angiogenesis by regulating
    CXCR4 or/and GSK-3β. PI3K, phosphoinositide 3-kinase; PDK1, 3-phosphoinositide-dependent
    kinase 1; AKT, v-akt murine thymoma viral oncogene homolog; SGK3, serum- and glucocorticoid-inducible
    protein kinase 3; Bcl-xL, B-cell lymphoma-extra large; FKHRs, forkhead family
    of transcription factors; BAD, Bcl-2-associated death promoter; FLI-I, flightless-I;
    GSK3-β, glycogen synthase kinase-β; TSC2, tuberous sclerosis factor 2; PTEN, phosphatase
    and tensin homolog; PRAS40, proline-rich AKT substrate of 40 kDa; SDF-1, stromal
    cell-derived factor 1; CXCR4, C-X-C chemokine receptor type 4; HIF1α, hypoxia-inducible
    factor-1α; VEGF, vascular endothelial growth factor; Id1, inhibitor of DNA binding/differentiation
    1; EPC, endothelial progenitor cell; KSHV vIL-6, Kaposi''s sarcoma-associated
    herpesvirus viral interleukin-6; HIV-1, human immunodeficiency virus type 1; Tat,
    transactivator of transcription; ER, estrogen receptor; AIP4, atrophin-1-interacting
    protein 4; FOXC2, forkhead box protein C2; Sp1, specificity protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT3
  - HIF1A
  - GSK3A
  - VEGFC
  - GSK3B
  - PDK1
  - AKT2
  - TSC2
  - ITCH
  - BCL2L1
  - CXCR4
  - BAD
  - SETD2
  - PGF
  - AKT1S1
  - FOXC2
  - SP1
  - VEGFB
  - VEGFD
  - VEGFA
  - PTEN
  - SGK3
  - FLII
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: GSK3-
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: GSK3-
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: TSC2,
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: AIP4
  symbol: AIP4
  source: hgnc_alias_symbol
  hgnc_symbol: ITCH
  entrez: '83737'
- word: BcL-xL,
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: GSK3-B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Bad,
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PRAS40,
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: FOXC2
  symbol: FOXC2
  source: hgnc_symbol
  hgnc_symbol: FOXC2
  entrez: '2303'
- word: SP1
  symbol: SP1
  source: hgnc_symbol
  hgnc_symbol: SP1
  entrez: '6667'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: SGK3
  symbol: SGK3
  source: hgnc_symbol
  hgnc_symbol: SGK3
  entrez: '23678'
- word: FLI-I
  symbol: FLII
  source: hgnc_symbol
  hgnc_symbol: FLII
  entrez: '2314'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
